InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
May 11, 2021 16:47 ET | Interpace Biosciences, Inc.
 ● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business  ● Q2 Revenue Expected to Exceed $11 million  ● On Track to Exceed Full Year 2021...
LOGO.jpg
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
March 31, 2021 17:20 ET | Interpace Biosciences, Inc.
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million Up 129% vs Prior Year; Provides Full Year 2021 Range of RevenuesOn Target to Achieve...
LOGO.jpg
Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and Completion of $5 Million Bridge Loan
January 20, 2021 08:30 ET | Interpace Biosciences, Inc.
Third Quarter Net Revenue of $8.2 Million Up 7% vs Prior Year; Third Quarter Year to Date Net Revenue of $22.8 Million Up 14% vs Prior YearEstimates Fourth Quarter Net Revenue range of $9.0 million -...
LOGO.jpg
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
June 25, 2020 16:59 ET | Interpace Biosciences, Inc.
First Quarter Net Revenue Improved Over 53% to $9.2 Million Launching COVID-19 Serology Testing Continues to Integrate Service Offerings and Streamline Costs Conference Call and Webcast Thursday...
Yesmail Interactive Makes it Easier for Marketers to Optimize Their Email Marketing Through Testing
January 31, 2013 09:40 ET | Yesmail
PORTLAND, Ore., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Yesmail Interactive, an Infogroup company which powers intelligent customer interactions, today announced its new test optimization solution. This new...